Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

D'Souza A, Lacy M, Gertz M, et al.

Blood · 2012

Grade Bcohortn=59Unverified

Key Findings

  • PFS 98% at 1 year, 75% at 5 years after ASCT
  • Clinical improvement nearly universal
  • VEGF response before ASCT predicted better 5-year PFS (90.9% vs 47.4%)

Referenced in (1 disease)

Validation history

Full log →

No validation events recorded yet. Source will be checked on the next kipine-source-validator run.

ID: pmid-22611150DOI: 10.1182/blood-2012-04-423178PMID: 22611150